BridgeBio Pharma (BBIO) News Today $54.26 +0.45 (+0.84%) Closing price 10/24/2025 04:00 PM EasternExtended Trading$56.29 +2.03 (+3.74%) As of 10/24/2025 07:57 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock BBIO Latest News All Sources Trusted Sources MarketBeat Barchart Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent October 2025 September 2025 August 2025 July 2025 June 2025 May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 Time Period BridgeBio Pharma to Host Business Update Calls for LGMD2I/R9 Phase 3 Results and Q3 2025 EarningsOctober 24 at 4:30 PM | quiverquant.comQBridgeBio to Report Phase 3 Results for Small Molecule BBP-418 in LGMD2I/R9 FORTIFY Study, along with Third Quarter 2025 Financial Results Next WeekOctober 24 at 4:01 PM | globenewswire.com4,851 Shares in BridgeBio Pharma, Inc. $BBIO Acquired by Phoenix Financial Ltd.October 24 at 5:05 AM | marketbeat.comBridgeBio Pharma (NASDAQ:BBIO) Price Target Raised to $59.00October 24 at 2:57 AM | americanbankingnews.comFNY Investment Advisers LLC Sells 7,836 Shares of BridgeBio Pharma, Inc. $BBIOOctober 23 at 6:12 AM | marketbeat.comRaymond James Maintains BridgeBio Pharma (BBIO) Outperform RecommendationOctober 22 at 1:19 PM | msn.comRaymond James Financial Raises BridgeBio Pharma (NASDAQ:BBIO) Price Target to $59.00October 21, 2025 | marketbeat.comPraxis Investment Management Inc. Buys Shares of 5,170 BridgeBio Pharma, Inc. $BBIOOctober 20, 2025 | marketbeat.comLeerink Partnrs Brokers Lift Earnings Estimates for BBIOOctober 18, 2025 | americanbankingnews.comBridgeBio Pharma, Inc. $BBIO Position Increased by WCM Investment Management LLCOctober 17, 2025 | marketbeat.comLeerink Partnrs Has Positive Estimate for BBIO Q3 EarningsOctober 16, 2025 | marketbeat.comBayforest Capital Ltd Acquires New Position in BridgeBio Pharma, Inc. $BBIOOctober 16, 2025 | marketbeat.com9,830 Shares in BridgeBio Pharma, Inc. $BBIO Bought by Vontobel Holding Ltd.October 15, 2025 | marketbeat.comKLP Kapitalforvaltning AS Raises Stock Position in BridgeBio Pharma, Inc. $BBIOOctober 15, 2025 | marketbeat.comRep. Gilbert Ray Cisneros, Jr. Buys BridgeBio Pharma, Inc. (NASDAQ:BBIO) StockOctober 14, 2025 | marketbeat.comDAVENPORT & Co LLC Makes New Investment in BridgeBio Pharma, Inc. $BBIOOctober 14, 2025 | marketbeat.comBridgeBio Pharma (NASDAQ:BBIO) Sets New 52-Week High - What's Next?October 13, 2025 | marketbeat.comSA Asks: What's the most attractive biotech stock right now?October 13, 2025 | msn.comOak Ridge Investments LLC Purchases New Holdings in BridgeBio Pharma, Inc. $BBIOOctober 12, 2025 | marketbeat.comBridgeBio Pharma (NASDAQ:BBIO) CEO Neil Kumar Sells 40,000 SharesOctober 11, 2025 | marketbeat.comNeil Kumar Sells 40,000 Shares of BridgeBio Pharma (NASDAQ:BBIO) StockOctober 11, 2025 | insidertrades.comBridgeBio Pharma (NASDAQ:BBIO) Given Sell (D-) Rating at Weiss RatingsOctober 9, 2025 | marketbeat.comBridgeBio Pharma, Inc. (NASDAQ:BBIO) Given Consensus Recommendation of "Moderate Buy" by BrokeragesOctober 8, 2025 | marketbeat.comBridgeBio Pharma (NASDAQ:BBIO) Sets New 12-Month High - Here's What HappenedOctober 6, 2025 | marketbeat.comPFG Investments LLC Takes Position in BridgeBio Pharma, Inc. $BBIOOctober 6, 2025 | marketbeat.comBridgeBio Pharma (BBIO) Is Up 5.6% After Acoramidis Shows Broad ATTR-CM Benefit in Phase 3 DataOctober 4, 2025 | finance.yahoo.comBridgeBio Pharma Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)October 3, 2025 | globenewswire.comPlatinum Investment Management Ltd. Grows Position in BridgeBio Pharma, Inc. $BBIOOctober 2, 2025 | marketbeat.comUBS Reaffirms Buy on BridgeBio (BBIO) With Optimism Around Attruby LaunchOctober 2, 2025 | msn.comBridgeBio Pharma, Inc. (BBIO) Presents at HFSA 2025 - SlideshowSeptember 30, 2025 | seekingalpha.comBridgeBio's Acoramidis Cuts Risk Within Weeks In Rare Heart ConditionSeptember 29, 2025 | finance.yahoo.comBridgeBio's Acoramidis Cuts Risk Within Weeks In Rare Heart ConditionSeptember 29, 2025 | benzinga.comBridgeBio Pharma, Inc.: Acoramidis Begins to Reduce Cumulative Cardiovascular Outcomes Within the First Month of Treatment in Patients with ATTR-CMSeptember 29, 2025 | finanznachrichten.deBridgeBio Pharma, Inc.: Acoramidis Begins to Reduce Cumulative Cardiovascular Outcomes Within the First Month of Treatment in Patients with ATTR-CMSeptember 29, 2025 | finanznachrichten.deMoss Adams Wealth Advisors LLC Has $1.04 Million Stock Position in BridgeBio Pharma, Inc. $BBIOSeptember 29, 2025 | marketbeat.comAcoramidis Begins to Reduce Cumulative Cardiovascular Outcomes Within the First Month of Treatment in Patients with ATTR-CMSeptember 28, 2025 | globenewswire.comBridgeBio Pharma’s Encaleret Shows Positive Phase 2 Results, Normalizes Calcium in Post-Surgical HypoparathyroidismSeptember 24, 2025 | msn.comRetirement Income Solutions Inc Acquires Shares of 5,000 BridgeBio Pharma, Inc. $BBIOSeptember 24, 2025 | marketbeat.comH.C. Wainwright Reiterates a Buy on BridgeBio Pharma (BBIO)September 24, 2025 | insidermonkey.comAssenagon Asset Management S.A. Has $15.13 Million Stake in BridgeBio Pharma, Inc. $BBIOSeptember 23, 2025 | marketbeat.comStrs Ohio Makes New Investment in BridgeBio Pharma, Inc. $BBIOSeptember 23, 2025 | marketbeat.comBridgeBio to Present Additional Cardiovascular Outcomes Data from ATTRibute-CM at the HFSA Annual Scientific Meeting 2025September 22, 2025 | globenewswire.comAtle Fund Management AB Buys 14,132 Shares of BridgeBio Pharma, Inc. $BBIOSeptember 21, 2025 | marketbeat.comBridgeBio Pharma (NASDAQ:BBIO) Shares Acquired Rep. Gilbert Ray Cisneros, Jr.September 17, 2025 | marketbeat.comIntech Investment Management LLC Purchases 7,877 Shares of BridgeBio Pharma, Inc. $BBIOSeptember 17, 2025 | marketbeat.comHC Wainwright Reaffirms "Buy" Rating for BridgeBio Pharma (NASDAQ:BBIO)September 16, 2025 | marketbeat.comBridgeBio Pharma, Inc. (NASDAQ:BBIO) Receives Average Rating of "Buy" from AnalystsSeptember 15, 2025 | marketbeat.comBridgeBio Pharma (NASDAQ:BBIO) Price Target Raised to $82.00September 14, 2025 | marketbeat.comBridgeBio Pharma (BBIO) Gets a Buy from Piper SandlerSeptember 12, 2025 | theglobeandmail.comPfizer, Alnylam earn BridgeBio ire over sales tactics for amyloidosis drugs: BloombergSeptember 12, 2025 | msn.com Get BridgeBio Pharma News Delivered to You Automatically Sign up to receive the latest news and ratings for BBIO and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. BBIO Media Mentions By Week BBIO Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. BBIO News Sentiment▼0.830.93▲Average Medical News Sentiment BBIO News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. BBIO Articles This Week▼1210▲BBIO Articles Average Week Get the Latest News and Ratings for BBIO and Related Stocks Enter your email address to receive the latest news and analysts' ratings for BridgeBio Pharma and its competitors. Sign Up View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. Related Companies and Tools Related Companies Insmed News BeOne Medicines News BioNTech News Teva Pharmaceutical Industries News Genmab A/S News Summit Therapeutics News Ascendis Pharma A/S News Dr. Reddy's Laboratories News Viatris News Roivant Sciences News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:BBIO) was last updated on 10/25/2025 by MarketBeat.com Staff From Our PartnersNEW LAW: Congress Approves Setup For Digital Dollar?Trump Ally Says Congress Approved the Setup for a Digital Dollar 2.0 But according to Rep. Marjorie Taylor ...Goldco Precious Metals | SponsoredIf You Keep Cash In A U.S. Bank Account… Read This NOWThe Treasury Department just issued a stunning warning: U.S. banks could lose up to $6.6 trillion of custom...Banyan Hill Publishing | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | Sponsored$100 Trillion “AI Metal” Found in American Ghost TownJeff Brown recently traveled to a ghost town in the middle of an American desert… To investigate what could...Brownstone Research | SponsoredClaim Your Share of $5.39 BILLION in AI Equity ChecksThe U.S. government just took advantage of Public Law 81-774 to crack down on AI companies... In turn, enfo...Angel Publishing | SponsoredMove $1,000 into this stock before Nov 6The End of Tesla? "Hold onto your Tesla stock." That's the message insiders at Tesla have been giving staff...Altimetry | SponsoredBuy UBER immediatelyBULLISH: It's time to buy this 'hidden' AI stock An award-winning stock-rating system has turned BULLISH on...Chaikin Analytics | Sponsored“Fed Proof” Your Bank Account with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding BridgeBio Pharma, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share BridgeBio Pharma With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
